Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4707306

CCNc1nc(N)nc2cc(-c3cccs3)c3c(ccn3CC)c12.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 2/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
TLR7 Q9NYK1 6/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HIF1A Q16665 1/20 0.34
DHFR P00374 1/20 0.34
PGK1 P00558 1/20 0.33
IKBKB O14920 1/20 0.33
APP P05067 1/20 0.32
ADORA2A P29274 1/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4706275 0.92 ALDH1A1 (0.36) PIK3CDPIK3CAPIK3CBPIK3CGTLR7
SCHEMBL4708196 0.92 NLRP3 (0.41) NLRP3TLR7ALDH1A1KMT2AHIF1A
Trifluoroacetic Acid SCHEMBL4710094 0.86 ALDH1A1 (0.36) PIK3CDPIK3CAPIK3CBPIK3CGALDH1A1
SCHEMBL4706335 0.84 TLR7 (0.37) NLRP3TLR7ALDH1A1MAPTKMT2A
Trifluoroacetic Acid SCHEMBL4708058 0.84 GBA1 (0.39) TLR7ALDH1A1MAPTKMT2ANPSR1
Trifluoroacetic Acid SCHEMBL5619136 0.82 SYK (0.34) TLR7ALDH1A1MAPTKMT2ANPSR1
Trifluoroacetic Acid SCHEMBL4707814 0.82 KMT2A (0.37) ALDH1A1MAPTKMT2ANPSR1KDM4E
Trifluoroacetic Acid SCHEMBL4690293 0.82 KDM4E (0.39) ALDH1A1KDM4EDHFRADORA2A
SCHEMBL4687413 0.81 F2R (0.42) DHFRADORA2A
SCHEMBL4708062 0.79 GBA1 (0.43) PIK3CDPIK3CAPIK3CBPIK3CGTLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633754-B1 DIAMINOPYRROLOQUINAZOLINES COMPOUNDS AS PROTEIN TYROSINE PHOSPHATASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-06-11 EP disclosed
US-7226915-B2 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors HOFFMANN-LA ROCHE INC. (US) 2007-06-05 US disclosed
US-20040229890-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors BERTHEL STEVEN JOSEPH (US) 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229890-A1 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors PTPN5, PTPRO, PTPN18 NLRP3 1979/4885PIK3CD 632/4885PIK3CA 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.